CN114903830A - 削弱过敏反应症状的组合物及防口罩脸面膜 - Google Patents
削弱过敏反应症状的组合物及防口罩脸面膜 Download PDFInfo
- Publication number
- CN114903830A CN114903830A CN202110179937.XA CN202110179937A CN114903830A CN 114903830 A CN114903830 A CN 114903830A CN 202110179937 A CN202110179937 A CN 202110179937A CN 114903830 A CN114903830 A CN 114903830A
- Authority
- CN
- China
- Prior art keywords
- component
- composition
- extract
- soothing
- repairing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种削弱过敏反应症状的组合物及防口罩脸面膜,所述组合物包括以下重量份的组分:0.01‑0.1份舒缓修护成分、0.1‑0.7份滋润成分、0.01‑0.25份辅助活性成分;所述舒缓修护成分为槲皮素、乳香、积雪草、广藿香、棕榈酰三肽‑8、四氢甲基嘧啶羧酸、花椒提取物、红没药醇、姜黄提取物中的一种或任意比例的多种;所述滋润成分为复活草提取物、益生菌发酵产物、透明质酸及其钠盐、银耳提取物、角鲨烷、霍霍巴油、海藻糖、维生素E、维生素E醋酸酯中的一种或任意比例的多种;所述辅助活性成分为多肽、深海微生物发酵产物、植物提取物中的一种或任意比例的多种。三个成分共同削弱过敏反应的“表象”,打到抗过敏目的。
Description
技术领域
本发明涉及化妆品技术领域,特别是涉及一种削弱过敏反应症状的组合物及防口罩脸面膜。
背景技术
口罩可有效阻断飞沫传播,降低传染疾病的感染率,但是人们在长期佩戴口罩的过程中,会造成各种面部不适,引起面部皮肤过敏,导致面部干燥、起屑、红肿、瘙痒、刺痛、红疹、痘痘等一系列皮肤问题,尤其是口鼻周围痤疮的爆发,这些皮肤问题常被称为口罩脸。
口罩脸的起因有以下四种:(1)口罩由不亲肤的无纺布或纤维材料制成,加之长时间与皮肤摩擦,容易刺激皮肤,引起过敏。(2)长时间佩戴口罩,人呼出的水蒸气会形成闷热潮湿的封闭环境,导致角质层水合过度,皮肤屏障功能受损。(3)湿热环境下,细菌会疯狂滋生,同时皮脂腺分泌也会变旺盛,出油增多,堵塞毛孔。(4)口罩消毒过程中残留的化学物质刺激皮肤,引发红肿。
现有技术中抗敏产品的工作原理一般分为以下几种:1)抑制组织胺与受体结合过程,减轻免疫系统激活的程度和过敏反应,比如苯海拉明、异丙嗪、氯苯那敏等,2)阻止组胺及其他过敏反应介质的释放,比如色甘酸钠,酮替芬等,3)减少组织胺在血液里的含量和浓度,比如维生素C等,4)反复刺激组胺HA受体,提高其对组胺的耐受性等。而这些抗敏产品对于由于佩戴口罩引起的过敏症状效果不佳,亟需一种针对于口罩脸的配方体系。
发明内容
本发明的目的是针对现有技术中存在现有抗敏产品对于口罩脸引起的面部症状效果不佳的问题,而提供削弱过敏反应症状的组合物。
本发明的另一目的是提供一种防口罩脸面膜。
为实现本发明的目的所采用的技术方案是:
削弱过敏反应症状的组合物,包括以下重量份的组分:
0.01-0.1份舒缓修护成分、0.1-0.7份滋润成分、0.01-0.25份辅助活性成分;
所述舒缓修护成分为槲皮素、乳香、积雪草、广藿香、棕榈酰三肽-8、四氢甲基嘧啶羧酸、花椒提取物、红没药醇、姜根提取物中的一种或任意比例的多种;
所述滋润成分为复活草提取物、益生菌发酵产物、透明质酸及其钠盐、银耳提取物、角鲨烷、霍霍巴油、海藻糖、维生素E、维生素E醋酸酯中的一种或任意比例的多种;
所述辅助活性成分为多肽、深海微生物发酵产物、植物提取物中的一种或任意比例的多种。
在上述技术方案中,还包括0.0001-0.1份辅料,所述辅料为芳香剂。
在上述技术方案中,所述舒缓修护成分由槲皮素、乳香、姜根提取物、广藿香和积雪草组成,其比例为(0.001-20.0):(0.001-60.0):(0.001-60.0):(0.0-10.0):(0.0-10.0)。
在上述技术方案中,所述辅助活性成分由多肽、深海微生物发酵产物和植物提取物组成,其比例不受限制;
其中所述多肽为乙酰基六肽-1、棕榈酰三肽-5、乙酰基六肽-8、寡肽-1或寡肽-2;
所述植物提取物为姜黄提取物或龙舌兰提取物。
本发明的另一方面,所述的削弱过敏反应症状的组合物在护肤产品中的应用。
本发明的另一方面,一种干膜,包括基膜和冻干形成于所述基膜上的所述的削弱过敏反应症状的组合物。
在上述技术方案中,所述的干膜,通过以下步骤制备:
步骤1,将所述削弱过敏反应症状的组合物溶于溶剂中形成冻干体系,每1份冻干体系中包括0.01-0.1份舒缓修护成分、0.1-0.7份滋润成分和0.01-0.25份辅助活性成分,或还包括0.0001-0.1份辅料,余量为溶剂;
步骤2,将所述冻干体系涂布于基膜上;
步骤3,冻干裁切成形。
在上述技术方案中,所述溶剂为去离子水、丁二醇、1,2-戊二醇、PEG-40氢化蓖麻油中的任意两种或多种组合。
本发明的另一方面,所述的干膜作为防口罩脸面膜的应用。
本发明的另一方面,所述的干膜作为药物敷贴的应用。
与现有技术相比,本发明的有益效果是:
1.本发明中的舒缓修护成分、滋润成分、辅助活性成分三者协同作用,舒缓修护成分起到镇定舒缓、抗炎脱敏的作用,滋润成分起到紧致、均匀肤色的作用,辅助活性成分起到细胞激活、修护微生态的作用;与传统抗敏产品的原理不同,三个成分通过“抗炎+滋润+激活细胞”相互协同,起到了增强机体自身血管的弹力,降低“过敏反应”激烈程度,减少毛细管扩张比例,减少破裂,从而削弱过敏反应的“表象”,打到抗过敏目的。
2.所述辅助活性成分由多肽、深海微生物发酵产物和植物提取物组成时,三种辅助活性成分具有相互促进的作用,多肽用于调节皮肤细胞,深海微生物发酵产物用于调节菌群微生态,植物提取物用于直接保湿或者吸收到循环系统起效,从细胞、微生态和皮肤环境三个层次上辅助舒缓修护成分,使其更好的发挥对于血管的作用。
具体实施方式
以下结合具体实施例对本发明作进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
实施例1
一种削弱过敏反应症状,包括0.01份舒缓修护成分、0.1份滋润成分、0.25份辅助活性成分;
所述舒缓修护成分包括0.001份槲皮素、0.003份棕榈酰三肽-8、0.002份红没药醇和0.004份姜根提取物;
所述滋润成分包括0.5份益生菌发酵产物和0.5份透明质酸;
所述辅助活性成分包括0.15份多肽和0.10份深海微生物发酵产物。
对比例1.1
其他成分与实施例1相同,但是不包括所述舒缓修护成分。
对比例1.2
其他成分与实施例1相同,但是不包括所述滋润成分。
对比例1.3
其他成分与实施例1相同,但是不包括所述辅助活性成分。
实施例2
一种削弱过敏反应症状,包括0.01份舒缓修护成分、0.7份滋润成分、0.1份辅助活性成分;
所述舒缓修护成分包括0.001份槲皮素、0.003份棕榈酰三肽-8、0.002份红没药醇和0.004份姜根提取物;
所述滋润成分包括0.5份银耳提取物和0.2份维生素E;
所述辅助活性成分包括0.03份龙舌兰提取物和0.07份深海微生物发酵产物。
选择125位面部敏感受试者,每天佩戴口罩时间为8小时,其中:
第一实验组选取25位,作为空白组;
第二实验组选取25位,于面部擦拭实施例1的组合物,早晚各一次;
第三实验组选取25位,于面部擦拭对比例1.1的组合物,早晚各一次;
第三实验组选取25位,于面部擦拭对比例1.2的组合物,早晚各一次;
第四实验组选取25位,于面部擦拭对比例1.3的组合物,早晚各一次;
第五实验组选取25位,于面部擦拭实施例2的组合物,早晚各一次;
两周后,得到以下实验结果:
第一实验组25位受试者面部均出现不同程度的红肿;
第二实验组6位受试者面部均出现红肿情况,19位受试者面部情况良好;
第三实验组20位受试者面部均出现红肿情况,5位受试者面部情况良好;
第四实验组19位受试者面部均出现红肿情况,6位受试者面部情况良好;
第五实验组5位受试者面部均出现红肿情况,20位受试者面部情况良好;
由上述实验结果可见,舒缓修护成分、滋润成分、辅助活性成分协同起到了削弱过敏反应的“表象”的作用,且缺一不可。
实施例3
本实施例中,所述舒缓修护成分由槲皮素、乳香、姜黄提取物、广藿香和积雪草组成,其比例为(0.001-20.0):(0.001-60.0):(0.001-60.0):(0.0-10.0):(0.0-10.0)。
3.1
一种削弱过敏反应症状,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由槲皮素、乳香、姜根提取物组成,其比例为10:30:0.1。
所述滋润成分包括0.5份益生菌发酵产物和0.5份透明质酸;
所述辅助活性成分包括0.15份多肽和0.10份深海微生物发酵产物。
3.2
一种削弱过敏反应症状,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由槲皮素、乳香、姜根提取物、广藿香和积雪草组成,其比例为0.001:60.0:30:2:2。
所述滋润成分包括0.3份霍霍巴油、0.3份海藻糖、0.1份维生素E;
所述辅助活性成分包括0.15份多肽和0.10份深海微生物发酵产物。
3.3
一种削弱过敏反应症状,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由乳香、姜根提取物、广藿香组成,其比例为10:60.0:0.2:2。
所述滋润成分包括0.3份霍霍巴油、0.3份海藻糖、0.1份维生素E;
所述辅助活性成分包括0.15份多肽和0.10份深海微生物发酵产物。
3.4
一种削弱过敏反应症状的组合物,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由乳香、姜根提取物、积雪草组成,其比例为10:60.0:0.2:2。
所述滋润成分包括0.3份霍霍巴油、0.3份海藻糖、0.1份维生素E;
所述辅助活性成分包括0.15份多肽和0.10份深海微生物发酵产物。
选择100位面部敏感受试者,每天佩戴口罩时间为8小时,其中:
第一实验组选取25位,于面部擦拭对比例3.1的组合物,早晚各一次;
第二实验组选取25位,于面部擦拭对比例3.2的组合物,早晚各一次;
第三实验组选取25位,于面部擦拭对比例3.3的组合物,早晚各一次;
第四实验组选取25位,于面部擦拭实施例3.4的组合物,早晚各一次;
两周后,得到以下实验结果:
第一实验组2位受试者面部均出现红肿情况,23位受试者面部情况良好;
第二实验组3位受试者面部均出现红肿情况,22位受试者面部情况良好;
第三实验组2位受试者面部均出现红肿情况,23位受试者面部情况良好;
第四实验组2位受试者面部均出现红肿情况,23位受试者面部情况良好;
由以上实验结果可见,在实施例1的基础上,对舒缓修护成分进行调整后,实施例3中的组合物,相比较于实施例1和实施例2中的组合物,削弱过敏反应的效果更佳。
实施例4
本实施例中,所述舒缓修护成分由槲皮素、乳香、姜根提取物、广藿香和积雪草组成,其比例为(0.001-20.0):(0.001-60.0):(0.001-60.0):(0.0-10.0):(0.0-10.0)。
本实施例中,辅助活性成分由多肽、深海微生物发酵产物和植物提取物组成,其比例为(1-100):(30-50):(0.1-1);
4.1
一种削弱过敏反应症状,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由槲皮素、乳香、姜根提取物组成,其比例为10:30:0.1。
所述滋润成分包括0.5份益生菌发酵产物和0.5份透明质酸;
所述辅助活性成分包括100份多肽、30份深海微生物发酵产物和0.4份姜黄提取物。
4.2
一种削弱过敏反应症状,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由槲皮素、乳香、姜根提取物、广藿香和积雪草组成,其比例为0.001:60.0:30:2:2。
所述滋润成分包括0.3份霍霍巴油、0.3份海藻糖、0.1份维生素E;
所述辅助活性成分包括1份多肽、50份深海微生物发酵产物和1份姜黄提取物。
4.3
一种削弱过敏反应症状,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由乳香、姜黄提取物、广藿香组成,其比例为10:60.0:0.2:2。
所述滋润成分包括0.3份霍霍巴油、0.3份海藻糖、0.1份维生素E;
所述辅助活性成分包括50份多肽、40份深海微生物发酵产物和0.1份植物提取物组龙舌兰提取物。
4.4
一种削弱过敏反应症状的组合物,包括0.1份舒缓修护成分、0.7份滋润成分、0.2份辅助活性成分;
所述舒缓修护成分由乳香、姜黄提取物、积雪草组成,其比例为10:60.0:0.2:2。
所述滋润成分包括0.3份霍霍巴油、0.3份海藻糖、0.1份维生素E;
所述辅助活性成分包括20份多肽、30份深海微生物发酵产物和0.5份龙舌兰提取物。
选择100位面部敏感受试者,每天佩戴口罩时间为8小时,其中:
第一实验组选取25位,于面部擦拭对比例3.1的组合物,早晚各一次;
第二实验组选取25位,于面部擦拭对比例3.2的组合物,早晚各一次;
第三实验组选取25位,于面部擦拭对比例3.3的组合物,早晚各一次;
第四实验组选取25位,于面部擦拭实施例3.4的组合物,早晚各一次;
两周后,得到以下实验结果:
第一实验组0位受试者面部均出现红肿情况,25位受试者面部情况良好;
第二实验组1位受试者面部均出现红肿情况,24位受试者面部情况良好;
第三实验组1位受试者面部均出现红肿情况,24位受试者面部情况良好;
第四实验组0位受试者面部均出现红肿情况,25位受试者面部情况良好;
由以上实验结果可见,在实施例1的基础上,在对舒缓修护成分和辅助活性成分进行调整后,实施例4中的组合物,相比较于实施例3中的组合物,削弱过敏反应的效果又有进一步的提高。
实施例5
在实施例1-4的基础上,在各组合物的基础上增加0.01份芳香剂,削弱过敏反应的效果相同。
实施例6
一种干膜通过以下方法制备:
步骤1,将实施例1-5中的组合物溶于溶剂中形成冻干体系,每1份冻干体系中包括0.01份舒缓修护成分、0.1份滋润成分和0.25份辅助活性成分,或还包括0.1份辅料,余量为溶剂;
步骤2,将所述冻干体系涂布于基膜上;
步骤3,冻干裁切成形。
将实施例1-5中的组合物制备形成干膜,每次使用时,去一定量的水或精华液喷涂于干膜上,敷于面部,削弱过敏反应的效果同实施例1-5相同。
以上所述仅是本发明的优选实施方式,应当指出的是,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (10)
1.削弱过敏反应症状的组合物,其特征在于,包括以下重量份的组分:
0.01-0.1份舒缓修护成分、0.1-0.7份滋润成分、0.01-0.25份辅助活性成分;
所述舒缓修护成分为槲皮素、乳香、积雪草、广藿香、棕榈酰三肽-8、四氢甲基嘧啶羧酸、花椒提取物、红没药醇、姜根提取物中的一种或任意比例的多种;
所述滋润成分为复活草提取物、益生菌发酵产物、透明质酸及其钠盐、银耳提取物、角鲨烷、霍霍巴油、海藻糖、维生素E、维生素E醋酸酯中的一种或任意比例的多种;
所述辅助活性成分为多肽、深海微生物发酵产物、植物提取物中的一种或任意比例的多种。
2.如权利要求1所述的削弱过敏反应症状的组合物,其特征在于,还包括0.0001-0.1份辅料,所述辅料为芳香剂。
3.如权利要求1所述的削弱过敏反应症状的组合物,其特征在于,所述舒缓修护成分由槲皮素、乳香、姜根提取物、广藿香和积雪草组成,其比例为(0.001-20.0):(0.001-60.0):(0.001-60.0):(0.0-10.0):(0.0-10.0)。
4.如权利要求1所述的削弱过敏反应症状的组合物,其特征在于,所述辅助活性成分由多肽、深海微生物发酵产物和植物提取物组成;
其中所述多肽为乙酰基六肽-1、棕榈酰三肽-5、乙酰基六肽-8、寡肽-1或寡肽-2;
所述植物提取物为姜黄提取物或龙舌兰提取物。
5.如权利要求1-4中任一项所述的削弱过敏反应症状的组合物在护肤产品中的应用。
6.一种干膜,包括基膜和冻干形成于所述基膜上的如权利要求1-4中任一项所述的削弱过敏反应症状的组合物。
7.如权利要求6所述的干膜,其特征在于,通过以下步骤制备:
步骤1,将所述削弱过敏反应症状的组合物溶于溶剂中形成冻干体系,每1份冻干体系中包括0.01-0.1份舒缓修护成分、0.1-0.7份滋润成分和0.01-0.25份辅助活性成分,或还包括0.0001-0.1份辅料,余量为溶剂;
步骤2,将所述冻干体系涂布于基膜上;
步骤3,冻干裁切成形。
8.如权利要求6所述的干膜,其特征在于,所述溶剂为去离子水、丁二醇、1,2-戊二醇、PEG-40氢化蓖麻油中的任意两种或多种组合。
9.如权利要求6所述的干膜作为防口罩脸面膜的应用。
10.如权利要求6所述的干膜作为药物敷贴的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110179937.XA CN114903830A (zh) | 2021-02-09 | 2021-02-09 | 削弱过敏反应症状的组合物及防口罩脸面膜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110179937.XA CN114903830A (zh) | 2021-02-09 | 2021-02-09 | 削弱过敏反应症状的组合物及防口罩脸面膜 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114903830A true CN114903830A (zh) | 2022-08-16 |
Family
ID=82760860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110179937.XA Pending CN114903830A (zh) | 2021-02-09 | 2021-02-09 | 削弱过敏反应症状的组合物及防口罩脸面膜 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114903830A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109464316A (zh) * | 2019-01-07 | 2019-03-15 | 广州市拓瑞科技有限公司 | 具有抗敏消炎功效的皮肤调理组合物、医用冷敷贴及其制备方法 |
CN110339143A (zh) * | 2019-08-15 | 2019-10-18 | 广东芭薇生物科技股份有限公司 | 一种紧致肌肤抗衰老面膜及其制备方法 |
CN111184662A (zh) * | 2019-10-18 | 2020-05-22 | 广州珂菲施诺生物科技有限公司 | 一种小分子肽肌底修护精华液 |
CN111249209A (zh) * | 2020-03-30 | 2020-06-09 | 广东芭薇生物科技股份有限公司 | 一种保湿修护霜及其制备方法 |
CN111450031A (zh) * | 2020-04-28 | 2020-07-28 | 刘科勇 | 冻干型纳米纤维隐形面膜及其制备方法 |
CN111450013A (zh) * | 2020-05-12 | 2020-07-28 | 广州怡嘉生物科技有限公司 | 一种修护原液 |
CN111544311A (zh) * | 2020-06-04 | 2020-08-18 | 云南贝泰妮生物科技集团股份有限公司 | 一种舒敏修护组合物、制剂、冻干面膜及制备方法 |
-
2021
- 2021-02-09 CN CN202110179937.XA patent/CN114903830A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109464316A (zh) * | 2019-01-07 | 2019-03-15 | 广州市拓瑞科技有限公司 | 具有抗敏消炎功效的皮肤调理组合物、医用冷敷贴及其制备方法 |
CN110339143A (zh) * | 2019-08-15 | 2019-10-18 | 广东芭薇生物科技股份有限公司 | 一种紧致肌肤抗衰老面膜及其制备方法 |
CN111184662A (zh) * | 2019-10-18 | 2020-05-22 | 广州珂菲施诺生物科技有限公司 | 一种小分子肽肌底修护精华液 |
CN111249209A (zh) * | 2020-03-30 | 2020-06-09 | 广东芭薇生物科技股份有限公司 | 一种保湿修护霜及其制备方法 |
CN111450031A (zh) * | 2020-04-28 | 2020-07-28 | 刘科勇 | 冻干型纳米纤维隐形面膜及其制备方法 |
CN111450013A (zh) * | 2020-05-12 | 2020-07-28 | 广州怡嘉生物科技有限公司 | 一种修护原液 |
CN111544311A (zh) * | 2020-06-04 | 2020-08-18 | 云南贝泰妮生物科技集团股份有限公司 | 一种舒敏修护组合物、制剂、冻干面膜及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110448509A (zh) | 一种具有舒敏修复功效的多肽精华液及其制备方法 | |
CN108478497B (zh) | 一种深层补水保湿组合物及其在护肤品中的应用 | |
CN110664716A (zh) | 乳化体系及应用、活性组合物及应用与化妆品及制备方法 | |
CN107334726B (zh) | 一种祛痘组合物及其制备方法和应用 | |
CN107174560B (zh) | 一种温和保湿舒缓卸妆水及其制备方法 | |
WO2006015675A1 (de) | Hautkosmetische zubereitung basierend auf mehrfach ungesättigten fetten | |
CN110731974A (zh) | 具有增强的抗炎功效的皮肤外用组合物 | |
CN115501143B (zh) | 一种含有雪莲培养物的抗敏舒缓组合物及其制备方法 | |
CN111973481A (zh) | 一种蓝酮肽修护精华及其制备方法 | |
KR20150135425A (ko) | 피부, 점막 및/또는 손톱의 치료 및/또는 관리를 위한 세포외 다당류 | |
CN112006958A (zh) | 脱毛膏及制备方法 | |
CN111973486A (zh) | 一种神经酰胺滋润保湿霜及其制备方法 | |
CN111973501A (zh) | 一种神经酰胺赋活乳及其制备方法 | |
CN108498390A (zh) | 一种治疗痤疮的藏本草提取物及其制备方法与应用 | |
CN113908097A (zh) | 一种祛痘组合物及其应用 | |
CN109199923A (zh) | 一种喷雾式睡眠面膜及其制备方法 | |
CN108553365A (zh) | 一种苹果肌丝滑面膜及其制备方法 | |
CN108619076A (zh) | 一种适用于敏感肌肤的美白保湿乳液 | |
CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
CN114903830A (zh) | 削弱过敏反应症状的组合物及防口罩脸面膜 | |
KR20210072966A (ko) | 나노캡슐화된 센텔라 추출물과 칼라민을 포함하는 피부보습 또는 피부염증 개선용 나노캡슐 조성물 | |
CN111973523A (zh) | 一种马齿苋抗敏修护面膜及其制备方法 | |
CN110585040A (zh) | 一种植物抑菌保湿面膜及其制备工艺 | |
KR102472059B1 (ko) | 모공 크기 축소용 미용패드 | |
KR101876744B1 (ko) | 홍삼추출물을 포함하는 화장품 조성물을 이용하여 피부를 3단계로 관리 개선하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220901 Address after: Tianning District Hehai road 213000 Jiangsu city of Changzhou province No. 9 Applicant after: CHANGZHOU YOUDUN INDUSTRIAL INVESTMENT CO.,LTD. Address before: 250000 Huihe Industrial Park, Zhaili Town, Laiwu nonggao District, Jinan City, Shandong Province Applicant before: Shandong Tantuo Agricultural Technology Co.,Ltd. |